Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000171 |
Acrolein |
CD8A gene mutant form inhibits the reaction [Acrolein results in increased activity of MMP2 protein] | decreases reaction|increases activity | 17950725
|
D000171 |
Acrolein |
CD8A gene mutant form inhibits the reaction [Acrolein results in increased activity of MMP9 protein] | decreases reaction|increases activity | 17950725
|
D000171 |
Acrolein |
CD8A gene mutant form inhibits the reaction [Acrolein results in increased expression of CXCL10 mRNA] | decreases reaction|increases expression | 17950725
|
D000171 |
Acrolein |
CD8A gene mutant form inhibits the reaction [Acrolein results in increased expression of IFNG mRNA] | decreases reaction|increases expression | 17950725
|
D000171 |
Acrolein |
CD8A gene mutant form inhibits the reaction [Acrolein results in increased expression of IL12B mRNA] | decreases reaction|increases expression | 17950725
|
D000171 |
Acrolein |
CD8A protein promotes the reaction [Acrolein results in increased activity of CASP3 protein] | increases activity|increases reaction | 17950725
|
D000171 |
Acrolein |
CD8A protein promotes the reaction [Acrolein results in increased expression of CCL2 mRNA] | increases expression|increases reaction | 17950725
|
D000171 |
Acrolein |
CD8A protein promotes the reaction [Acrolein results in increased expression of CCL5 mRNA] | increases expression|increases reaction | 17950725
|
D020875 |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [Carbon Tetrachloride results in increased expression of CD8A mRNA] | decreases reaction|increases expression | 17299060
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of CD8A mRNA | affects expression | 16483693
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of CD8A mRNA | increases expression | 17299060
|
D002251 |
Carbon Tetrachloride |
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- inhibits the reaction [Carbon Tetrachloride results in increased expression of CD8A mRNA] | decreases reaction|increases expression | 17299060
|
D003513 |
Cycloheximide |
[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of CD8A mRNA | affects cotreatment|increases expression | 19684285
|
D003561 |
Cytarabine |
Cytarabine results in increased expression of CD8A mRNA | increases expression | 19194470
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of CD8A mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of CD8A mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CD8A mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of CD8A mRNA | decreases expression | 15576828
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of CD8A mRNA | increases expression | 18035473
|
D005472 |
Fluorouracil |
TP53 protein affects the reaction [Fluorouracil results in decreased expression of CD8A mRNA] | affects reaction|decreases expression | 15016801
|
D008727 |
Methotrexate |
Methotrexate results in decreased expression of CD8A protein | decreases expression | 15476228
|
C029938 |
nickel sulfate |
nickel sulfate results in increased expression of CD8A mRNA | increases expression | 16780908
|
D010615 |
Phenacetin |
Phenacetin results in decreased expression of CD8A mRNA | decreases expression | 17698508
|
C030299 |
phenylhydrazine |
phenylhydrazine results in decreased expression of CD8A mRNA | decreases expression | 17698508
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of CD8A mRNA | decreases expression | 17426115
|
D020849 |
Raloxifene |
Raloxifene affects the expression of CD8A mRNA | affects expression | 16079270
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Cycloheximide] results in increased expression of CD8A mRNA | affects cotreatment|increases expression | 19684285
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of CD8A mRNA | decreases expression | 19684285
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CD8A mRNA | affects cotreatment|increases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
8.66 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
8.66 | 14514962 15322242 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.58 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.97 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Acrolein |
15.46 | 20525806 21297076 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
15.46 | 19131640 12718980 11954676 16100012 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
15.46 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.34 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.34 | 17638652 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.97 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.97 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.60 | 17451421 17308373 |
MESH:D000544 |
Alzheimer Disease |
|
Acrolein |
4.68 | 17570602 14715435 15207723 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
4.68 | 15800139 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
21.33 | 16511603 15504547 17963324 |
MESH:D000740 |
Anemia |
|
Phenacetin |
21.33 | 2444515 |
MESH:D000740 |
Anemia |
|
phenylhydrazine |
21.33 | 2444515 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
21.33 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Phenacetin |
11.07 | 17082564 17698508 1949026 |
MESH:D000743 |
Anemia, Hemolytic |
|
phenylhydrazine |
11.07 | 17082564 17084956 17698508 |
MESH:D001161 |
Arteriosclerosis |
|
Acrolein |
10.37 | 15014928 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
10.37 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.66 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.10 | 17286800 |
MESH:D050197 |
Atherosclerosis |
|
Acrolein |
3.98 | 16126721 16037261 17363696 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.78 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.78 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.82 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.76 | 15746008 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.49 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.01 | 15136595 16557594 18357371 16595493 18608205 16110121 19217205 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.01 | 16978400 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
2.01 | 17893378 17595753 16912660 17242785 15572757 17049068 17952589 16837676 17261762 17440819 15758505 15775269 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.01 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.79 | 3786805 16097048 15673190 16011737 16227642 16124888 15721981 18705752 15700767 10355542 16050911 16192424 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.70 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.19 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
8.19 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
3.11 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
3.11 | 18930000 16332177 16799960 17088986 17971768 17045692 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.02 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
2.49 | 18986760 16757204 17066447 16280240 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
4.08 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.37 | 16120746 18850075 18670907 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.45 | 15775269 |
OMIM:608957 |
CD8 DEFICIENCY, FAMILIAL |
marker/mechanism |
|
| |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cytarabine |
4.26 | 8243401 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.16 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
7.75 | 17110522 17681005 15861022 17333356 11677210 16919318 16105132 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.75 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.10 | 8697196 15340226 16354765 12621046 15668235 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.63 | 15800139 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.23 | 18772588 17287894 17725105 17172411 16510598 16340194 15001691 17018589 17169374 17016597 |
MESH:D015179 |
Colorectal Neoplasms |
|
Acrolein |
2.94 | 17597105 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.94 | 16391804 16303861 17695437 17594712 18448328 14970324 16524972 15289873 15148649 17454858 16282729 17094418 17401013 18509181 18802399 17255274 20501625 18383874 16331619 17016601 18949393 18288408 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.06 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
2.75 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.75 | 15322242 10048152 20055451 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.24 | 19747007 |
MESH:D003556 |
Cystitis |
|
Acrolein |
5.42 | 12161096 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.81 | 16733453 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.16 | 17474826 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
3.69 | 16780908 11298694 16823706 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.43 | 18249437 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.13 | 20191521 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
3.94 | 17451421 17308373 15920148 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
3.73 | 15998439 6884620 11566570 3786805 9327722 10092053 17522070 7120509 16227642 15027814 6623471 7179309 4309450 19336974 21278145 3732212 10915739 16177239 19085960 2869522 7440962 15968718 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.73 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.76 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
11.46 | 12083418 |
MESH:D004487 |
Edema |
|
Raloxifene |
11.46 | 15860553 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
11.46 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.93 | 16714409 15322242 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.15 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
9.15 | 15845917 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.02 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
2.45 | 16481741 16337965 17638652 15173087 16785472 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.01 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
18.82 | 12795759 17595544 16045604 19224547 12631006 16239168 15959796 61145 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
18.82 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
18.82 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
18.82 | 17473493 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.47 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
8.64 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.64 | 20067830 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.87 | 16145905 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.62 | 10696789 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.16 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.39 | 15162350 15102660 18337622 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.33 | 11294989 10048152 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.54 | 11110106 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.54 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.34 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.60 | 19900420 19110552 |
MESH:D006526 |
Hepatitis C |
|
Enkephalin, Ala(2)-MePhe(4)-Gly(5)- |
6.11 | 17299060 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.31 | 19772884 19176532 18467677 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.31 | 16120746 12621046 15340226 |
MESH:D006689 |
Hodgkin Disease |
|
Cytarabine |
4.42 | 16200630 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.08 | 15340226 8697196 16959395 18606429 16354765 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.55 | 16899240 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.19 | 20558911 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
5.23 | 15787275 17577099 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.23 | 18850075 18670907 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.10 | 15338365 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.82 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.47 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.49 | 17937319 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
5.00 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.00 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.63 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Acrolein |
3.84 | 12488133 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
3.31 | 16985049 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.11 | 9562676 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.50 | 16973256 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.94 | 16943688 11903743 21278145 17157831 11408273 17334410 16239168 17174718 16221502 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
6.94 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.39 | 15338365 15876570 18412020 17805973 16136751 12632514 18054572 15123356 17922224 12586293 17714472 15673190 16638106 12741479 16248980 18339082 18210741 17761835 15931870 15996030 12546737 17708605 18395914 17631135 18251166 16192424 18277467 17766677 18472094 15362042 17557913 12632512 12649538 18187930 18376398 17640975 12898905 15730626 17869086 12958196 18472332 12445421 15818738 10355542 17481882 17721639 14748882 18006644 13678700 16097048 16027843 18395095 17823541 15925388 18418968 18205269 18166357 17944888 17698563 18156304 16011737 14620537 15052691 17900296 18317297 16116963 12609069 18279442 15650968 14716833 17565644 12666154 16015684 12389079 15370692 17525996 16033810 18263696 18429990 12667390 12445418 15959796 18481824 14512876 20821823 18705752 15893842 17976157 11481614 18420326 14716496 14724832 15057751 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.39 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.39 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.08 | 15830285 17285989 15720792 16964402 16246199 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.18 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.69 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
10.69 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
10.69 | 15113037 17045692 18383874 16603448 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.69 | 16377806 20007298 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.69 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
5.76 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.76 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Acrolein |
4.21 | 11504702 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
5.05 | 18516814 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
2.34 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.34 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.81 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
3.95 | 17352296 |
MESH:D008546 |
Melanoma, Experimental |
|
Acrolein |
5.22 | 10803710 |
MESH:D008708 |
Methemoglobinemia |
|
Phenacetin |
4.96 | 16296465 3537620 4834387 1949026 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.58 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.63 | 18986760 16757204 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.30 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.44 | 16497877 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.52 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.14 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.02 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.95 | 16411023 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.58 | 16343187 |
MESH:D009369 |
Neoplasms |
|
Acrolein |
8.41 | 17329238 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
8.41 | 18239605 16928823 18600527 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.41 | 17405874 |
MESH:D009393 |
Nephritis |
|
Acrolein |
6.32 | 12653641 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.22 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acrolein |
4.51 | 11342003 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.44 | 16436463 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.81 | 20558911 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.39 | 17882678 15775268 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.23 | 17823083 15579764 15758505 17893378 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.66 | 16500647 16929163 15113037 19003803 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.69 | 11578682 |
MESH:D010300 |
Parkinson Disease |
|
Acrolein |
3.59 | 17690948 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.28 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
Acrolein |
5.77 | 11550810 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.57 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cytarabine |
4.44 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.21 | 11896295 11399792 11118676 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.46 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
3.46 | 16536755 16220300 15731164 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.33 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.43 | 17410198 |
MESH:D029424 |
Pulmonary Disease, Chronic Obstructive |
marker/mechanism |
|
| 17950725 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.58 | 15770314 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.01 | 16160472 15538739 18286688 18722050 |
MESH:D051437 |
Renal Insufficiency |
|
Acrolein |
10.82 | 12732208 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
10.82 | 17352296 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.39 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.85 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.04 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
3.97 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.00 | 16951190 17172411 19015929 19084572 18396642 18567086 16424979 17522103 15786421 17498489 |
MESH:D020521 |
Stroke |
|
Acrolein |
9.10 | 16269634 |
MESH:D020521 |
Stroke |
|
Raloxifene |
9.10 | 16837676 |
MESH:D013436 |
Sulfhemoglobinemia |
|
Phenacetin |
6.59 | 978859 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.04 | 9562676 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.63 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.15 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.93 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
5.24 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.99 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Phenacetin |
5.77 | 11144890 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
5.77 | 17572228 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
3.88 | 16803524 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.31 | 14692618 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.62 | 12125929 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.24 | 16837676 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.54 | 14671159 15869587 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.58 | 16343187 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.28 | 15886252 |